A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma

Ajai Chari; Amitabha Mazumder; Kenneth Lau; Donna Catamero; Zachary Galitzeck; Sundar Jagannath

doi:10.1111/bjh.14314

A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma

Ajai Chari, Amitabha Mazumder, Kenneth Lau, Donna Catamero, Zachary Galitzeck, Sundar Jagannath

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	296-298
Number of pages	3
Journal	British Journal of Haematology
Volume	180
Issue number	2
DOIs	https://doi.org/10.1111/bjh.14314
State	Published - Jan 2018

Keywords

cancer
myeloma
myeloma therapy
risk factors

Access to Document

10.1111/bjh.14314

Cite this

@article{4bcb0d2c0f72411994415580e8d84b81,

title = "A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma",

keywords = "cancer, myeloma, myeloma therapy, risk factors",

author = "Ajai Chari and Amitabha Mazumder and Kenneth Lau and Donna Catamero and Zachary Galitzeck and Sundar Jagannath",

note = "Funding Information: The following authors received research funding from the identified companies: AC from Array BioPharma; AC from Novartis; AC from Millennium/Takeda; AC from Celgene; AC from Amgen-Onyx; AC from Janssen. Drug supply was provided by Unicorn Pacific Corporation (Port Vila, Vanuatu), which manufactures TBL-12.",

year = "2018",

month = jan,

doi = "10.1111/bjh.14314",

language = "English",

volume = "180",

pages = "296--298",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma

AU - Chari, Ajai

AU - Mazumder, Amitabha

AU - Lau, Kenneth

AU - Catamero, Donna

AU - Galitzeck, Zachary

AU - Jagannath, Sundar

N1 - Funding Information: The following authors received research funding from the identified companies: AC from Array BioPharma; AC from Novartis; AC from Millennium/Takeda; AC from Celgene; AC from Amgen-Onyx; AC from Janssen. Drug supply was provided by Unicorn Pacific Corporation (Port Vila, Vanuatu), which manufactures TBL-12.

PY - 2018/1

Y1 - 2018/1

KW - cancer

KW - myeloma

KW - myeloma therapy

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=84990983985&partnerID=8YFLogxK

U2 - 10.1111/bjh.14314

DO - 10.1111/bjh.14314

M3 - Letter

C2 - 27714761

AN - SCOPUS:84990983985

SN - 0007-1048

VL - 180

SP - 296

EP - 298

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -